Meeting of the Tick-Borne Disease Working Group
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
As required by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the Tick-Borne Disease Working Group (TBDWG) will hold a meeting. The meeting will be open to the public via webcast. For this meeting, the TBDWG will (1) review the final draft of chapters for the report and (2) further discuss plans for developing the next report to the HHS Secretary and Congress on federal tick-borne activities and research, taking into consideration the 2018 and 2020 report. The 2022 report will address a wide range of topics related to tick-borne diseases, such as, surveillance, prevention, diagnosis, diagnostics, and treatment; identify advances made in research, as well as overlap and gaps in tick-borne disease research; and provide recommendations regarding any appropriate changes or improvements to such activities and research.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 170 (Friday, September 2, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 170 (Friday, September 2, 2022)]
[Notices]
[Pages 54224-54225]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-18972]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Tick-Borne Disease Working Group
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As required by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the Tick-Borne Disease Working Group (TBDWG) will hold a meeting.
The meeting will be open to the public via webcast. For this meeting,
the TBDWG will (1) review the final draft of chapters for the report
and (2) further discuss plans for developing the next report to the HHS
Secretary and Congress on federal tick-borne activities and research,
taking into consideration the 2018 and 2020 report. The 2022 report
will address a wide range of topics related to tick-borne diseases,
such as, surveillance, prevention, diagnosis, diagnostics, and
treatment; identify advances made in research, as well as overlap and
gaps in tick-borne disease research; and provide recommendations
regarding any appropriate changes or improvements to such activities
and research.
DATES: The public can view the meeting online via webcast on October 4-
5, 2022
[[Page 54225]]
from approximately 9 a.m. to 5 p.m. ET (times are tentative and subject
to change) each day. The confirmed times and agenda items for the
meeting will be posted on the TBDWG web page at <a href="https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-04/index.html">https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-04/index.html</a>
when this information becomes available.
FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS
Policy, Office of the Assistant Secretary for Health, Department of
Health and Human Services, Mary E. Switzer Building, 330 C Street SW,
Suite L600, Washington, DC 20024. Email: <a href="/cdn-cgi/l/email-protection#24504d474f464b564a41404d5741455741644c4c570a434b52"><span class="__cf_email__" data-cfemail="75011c161e171a071b10111c0610140610351d1d065b121a03">[email protected]</span></a>.
Phone: 202-795-7608.
SUPPLEMENTARY INFORMATION: A link to view the webcast can be found on
the meeting website at <a href="https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-04/index.html">https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-04/index.html</a> when it becomes
available. The public will have an opportunity to present their views
to the TBDWG orally during the meeting's public comment session or by
submitting a written public comment. Comments should be pertinent to
the meeting discussion. Persons who wish to provide verbal or written
public comment should review instructions at <a href="https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-04/index.html">https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-04/index.html</a> and
respond by midnight September 26, 2022 ET. Verbal comments will be
limited to three minutes each to accommodate as many speakers as
possible during the 30-minute session. Written public comments will be
accessible to the public on the TBDWG web page prior to the meeting.
Background and Authority: The Tick-Borne Disease Working Group was
established on August 10, 2017, in accordance with Section 2062 of the
21st Century Cures Act, and the Federal Advisory Committee Act, 5
U.S.C. App., as amended, to provide expertise and review federal
efforts related to all tick-borne diseases, to help ensure interagency
coordination and minimize overlap, and to examine research priorities.
The TBDWG is required to submit a report to the HHS Secretary and
Congress on their findings and any recommendations for the federal
response to tick-borne disease every two years.
Dated: August 23, 2022.
James J. Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Office of
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2022-18972 Filed 9-1-22; 8:45 am]
BILLING CODE 4150-28-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.